HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tyrosine-phosphorylated galectin-3 protein is resistant to prostate-specific antigen (PSA) cleavage.

Abstract
Galectin-3 is a chimeric carbohydrate-binding protein, which interacts with cell surface carbohydrate-containing molecules and extracellular matrix glycoproteins and has been implicated in various biological processes such as cell growth, angiogenesis, motility, and metastasis. It is expressed in a wide range of tumor cells and is associated with tumor progression. The functions of galectin-3 are dependent on its localization and post-translational modifications such as cleavage and phosphorylation. Recently, we showed that galectin-3 Tyr-107 is phosphorylated by c-Abl; concomitantly, it was also shown that galectin-3 can be cleaved at this site by prostate-specific antigen (PSA), a chymotrypsin-like serine protease, after Tyr-107, resulting in loss of galectin-3 multivalency while preserving its carbohydrate binding activity. Galectin-3 is largely a monomer in solution but may form a homodimer by self-association through its carbohydrate recognition domain, whereas, in the presence of a ligand, galectin-3 polymerizes up to pentamers utilizing its N-terminal domain. Oligomerization is a unique feature of secreted galectin-3, which allows its function by forming ordered galectin-glycan structures, i.e. lattices, on the cell surface or through direct engagement of specific cell surface glycoconjugates by traditional ligand-receptor binding. We questioned whether Tyr-107 phosphorylation by c-Abl affects galectin-3 cleavage by PSA. The data suggest a role for galectin-3 in prostate cells associated with increased activity of c-Abl kinase and loss of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) activity. In addition, the ratio of phosphorylated/dephosphorylated galectin-3 might be used as a complementary value to that of PSA for prognosis of prostate cancer and a novel therapeutic target for the treatment of prostate cancer.
AuthorsVitaly Balan, Pratima Nangia-Makker, Dhong Hyo Kho, Yi Wang, Avraham Raz
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 287 Issue 8 Pg. 5192-8 (Feb 17 2012) ISSN: 1083-351X [Electronic] United States
PMID22232548 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Galectin 3
  • Tyrosine
  • Proto-Oncogene Proteins c-abl
  • Phosphoric Monoester Hydrolases
  • PTEN Phosphohydrolase
  • Prostate-Specific Antigen
Topics
  • Cell Line, Tumor
  • Chemotaxis
  • Extracellular Space (metabolism)
  • Galectin 3 (chemistry, metabolism)
  • Humans
  • Models, Molecular
  • Neovascularization, Pathologic (metabolism)
  • PTEN Phosphohydrolase (metabolism)
  • Phosphoric Monoester Hydrolases (metabolism)
  • Phosphorylation
  • Prostate-Specific Antigen (metabolism)
  • Protein Conformation
  • Proteolysis
  • Proto-Oncogene Proteins c-abl (metabolism)
  • Tyrosine (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: